Pfizer Profit Beats Analyst Estimates on Lower Costs

Pfizer Profit Beats Analyst Estimates on Lower Costs

JB Reed/Bloomberg

Pfizer’s Lipitor had sales of $2.39 billion in the first quarter falling short of the $2.55 billion average estimate of five analysts surveyed by Bloomberg.